semaglutide and coffee aversion Weight-Loss Drug Making People Disgusted by Coffee, Fries Your Morning Brew and GLP-1s:

Plaintiffs counter that their complaint includes broader allegations, such as deceptive marketing, negligence, breach of warranty, and product design flaws

A new federal multidistrict litigation docket has been established to centralize lawsuits alleging that glucagonlike peptide1 (GLP1) receptor agonist drugs, including Ozempic, Wegovy, Rybelsus, Mounjaro, and others, caused serious vision loss linked to nonarteritic anterior ischemic optic neuropathy (NAION)

People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should review label contraindications with a clinician

Epitalon affects telomerase activity and telomere length

Y, al menos, una enfermedad asociada al exceso de peso